Occupational Therapists in Avon, CT Accepting Medicare

25 Occupational Therapists found. Showing 21 - 25

Ms. Alexandra Nicole Poppiti Occupational Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779    Fax: 860-409-2190

Rebecca Souza, RPT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779

Mrs. Nicole Peloso Smith, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Allstar, Avon, CT 06001 Phone: 860-678-9755

Ms. Susan Ellen Carey, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 49 W Main St, Avon, CT 06001 Phone: 860-284-9779    Fax: 860-409-2190

Dr. Kathleen Ann Subasic, OTR/L Occupational Therapist - Environmental Modification Medicare: Not Enrolled in Medicare Practice Location: 19 Stockbridge Dr, Avon, CT 06001 Phone: 860-829-7870

News Archive

Study to investigate how dietary iron is used by cells

A four-year study on iron metabolism within cells, an essential process that impacts both iron deficiency and iron toxicity, conditions responsible for a multitude of human diseases, is underway at the University at Buffalo funded by a $1.16 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Lab-on-a-chip performs 1,000 chemical reactions at once

Flasks, beakers, and hot plates may soon be a thing of the past in medicinal chemistry labs. Instead of handling a few experiments on a benchtop, scientists may simply pop a microchip into a computer and instantly run thousands of chemical reactions, with results literally shrinking the lab down to the size of a thumbnail.

Study discovers mechanism by which bioscaffolds influence cellular behavior

A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago.

New immunosuppressive regimens may improve outcomes for kidney transplant patients

Preliminary results from a $5.2 million clinical trial led by University of Cincinnati researchers show that the immunosuppressive drug belatacept can help safely and effectively treat kidney transplant patients without the negative long-term side effects of traditional immunosuppressive regimens, the study's leaders announced this week.

Can dexamethasone reduce prolonged COVID-19 symptoms?

A new study assesses hospitalized patients after recovering from COVID-19 by comparing the individuals before and after being treated with dexamethasone.

Read more Medical News

› Verified 7 days ago

• 1
• 2(current)